Matches in SemOpenAlex for { <https://semopenalex.org/work/W3152919093> ?p ?o ?g. }
Showing items 1 to 67 of
67
with 100 items per page.
- W3152919093 abstract "Multiple myeloma is the third most common hematologic malignancy in Malaysia. The introduction of novel agents over the past decades has improved patient outcome and survival substantially. The usage of novel agents can be financially taxing, and hence resources limit its use. This study aims to report on the real-world treatment outcome when resources are limited. This is a retrospective study on newly diagnosed multiple myeloma (NDMM) patients diagnosed between 1 January 2008 and 31 December 2018 in a single academic center. Patients demographic and type of treatment were included for analysis of progression free survival and overall survival. Ninety-eight NDMM patients with a median age of 63.5 (ranged from 38 to 87 years old) were included. Half of the total patients received bortezomib-containing regimens while 40.8% received thalidomide-containing regimens, and remaining 9.2% had other agents as induction. Forty-seven patients (48.0%) achieved very good partial response (VGPR) or complete remission (CR), while remaining 51 patients (52.0%) have achieved partial response (PR) at best during induction therapy. Bortezomib use was associated with significantly deeper (p=0.001) and more rapid response (p=0.005) compared to other agents. Five-year OS and PFS were 45.3% and 18.4%, respectively. Triplet regimen, best initial response and upfront ASCT were significantly associated with better PFS. In conclusion, deep response significantly affects PFS and OS in NDMM patients. Thus, one of the goals of treatment is to ensure earlier and deeper response by including bortezomib as part of triplet combination in upfront therapy, followed by ASCT for those who are fit. This is feasible in a resource limited country such as Malaysia, especially there is a cheaper generic formulation." @default.
- W3152919093 created "2021-04-26" @default.
- W3152919093 creator A5010285940 @default.
- W3152919093 creator A5023900711 @default.
- W3152919093 creator A5027946168 @default.
- W3152919093 creator A5038842167 @default.
- W3152919093 creator A5057066150 @default.
- W3152919093 creator A5064033949 @default.
- W3152919093 creator A5088673687 @default.
- W3152919093 creator A5090331601 @default.
- W3152919093 date "2021-04-08" @default.
- W3152919093 modified "2023-09-27" @default.
- W3152919093 title "Treatment outcome of newly diagnosed multiple myeloma patients: A retrospective analysis in a resource-limited setting" @default.
- W3152919093 doi "https://doi.org/10.22541/au.161789033.39632939/v1" @default.
- W3152919093 hasPublicationYear "2021" @default.
- W3152919093 type Work @default.
- W3152919093 sameAs 3152919093 @default.
- W3152919093 citedByCount "0" @default.
- W3152919093 crossrefType "posted-content" @default.
- W3152919093 hasAuthorship W3152919093A5010285940 @default.
- W3152919093 hasAuthorship W3152919093A5023900711 @default.
- W3152919093 hasAuthorship W3152919093A5027946168 @default.
- W3152919093 hasAuthorship W3152919093A5038842167 @default.
- W3152919093 hasAuthorship W3152919093A5057066150 @default.
- W3152919093 hasAuthorship W3152919093A5064033949 @default.
- W3152919093 hasAuthorship W3152919093A5088673687 @default.
- W3152919093 hasAuthorship W3152919093A5090331601 @default.
- W3152919093 hasBestOaLocation W31529190931 @default.
- W3152919093 hasConcept C126322002 @default.
- W3152919093 hasConcept C141071460 @default.
- W3152919093 hasConcept C143998085 @default.
- W3152919093 hasConcept C167135981 @default.
- W3152919093 hasConcept C2776364478 @default.
- W3152919093 hasConcept C2777478702 @default.
- W3152919093 hasConcept C2779399171 @default.
- W3152919093 hasConcept C2779609412 @default.
- W3152919093 hasConcept C2780073493 @default.
- W3152919093 hasConcept C2781413609 @default.
- W3152919093 hasConcept C71924100 @default.
- W3152919093 hasConceptScore W3152919093C126322002 @default.
- W3152919093 hasConceptScore W3152919093C141071460 @default.
- W3152919093 hasConceptScore W3152919093C143998085 @default.
- W3152919093 hasConceptScore W3152919093C167135981 @default.
- W3152919093 hasConceptScore W3152919093C2776364478 @default.
- W3152919093 hasConceptScore W3152919093C2777478702 @default.
- W3152919093 hasConceptScore W3152919093C2779399171 @default.
- W3152919093 hasConceptScore W3152919093C2779609412 @default.
- W3152919093 hasConceptScore W3152919093C2780073493 @default.
- W3152919093 hasConceptScore W3152919093C2781413609 @default.
- W3152919093 hasConceptScore W3152919093C71924100 @default.
- W3152919093 hasLocation W31529190931 @default.
- W3152919093 hasOpenAccess W3152919093 @default.
- W3152919093 hasPrimaryLocation W31529190931 @default.
- W3152919093 hasRelatedWork W1972519999 @default.
- W3152919093 hasRelatedWork W2013163224 @default.
- W3152919093 hasRelatedWork W2112489854 @default.
- W3152919093 hasRelatedWork W2427804748 @default.
- W3152919093 hasRelatedWork W2559593973 @default.
- W3152919093 hasRelatedWork W2988379501 @default.
- W3152919093 hasRelatedWork W3022132370 @default.
- W3152919093 hasRelatedWork W3031718141 @default.
- W3152919093 hasRelatedWork W32729895 @default.
- W3152919093 hasRelatedWork W4241469660 @default.
- W3152919093 isParatext "false" @default.
- W3152919093 isRetracted "false" @default.
- W3152919093 magId "3152919093" @default.
- W3152919093 workType "article" @default.